Phytofabrication of Nanoparticles as Novel Drugs for Anticancer Applications.
Qi-Yao WeiKai-Ming HeJin-Ling ChenYan-Ming XuAndy T Y LauPublished in: Molecules (Basel, Switzerland) (2019)
Cancer is one of the foremost causes of death globally and also the major stumbling block of increasing life expectancy. Although the primary treatment of surgical resection, chemotherapy, and radiotherapy have greatly reduced the mortality of cancer, the survival rate is still low because of the metastasis of tumor, a range of adverse drug reactions, and drug resistance. For all this, it is relevant to mention that a growing amount of research has shown the anticarcinogenic effect of phytochemicals which can modulate the molecular pathways and cellular events include apoptosis, cell proliferation, migration, and invasion. However, their pharmacological potential is hindered by their low water solubility, low stability, poor absorption, and rapid metabolism. In this scenario, the development of nanotechnology has created novel formulations to maximize the potential use of phytochemicals in anticancer treatment. Nanocarriers can enhance the solubility and stability of phytochemicals, prolong their half-life in blood and even achieve site-targeting delivery. This review summarizes the advances in utilizing nanoparticles in cancer therapy. In particular, we introduce several applications of nanoparticles combined with apigenin, resveratrol, curcumin, epigallocatechin-3-gallate, 6-gingerol, and quercetin in cancer treatment.
Keyphrases
- cancer therapy
- adverse drug
- cell proliferation
- papillary thyroid
- drug delivery
- squamous cell
- locally advanced
- oxidative stress
- combination therapy
- cell death
- lymph node metastasis
- squamous cell carcinoma
- radiation therapy
- type diabetes
- cell cycle
- signaling pathway
- risk factors
- walled carbon nanotubes
- radiation induced
- cell cycle arrest
- childhood cancer
- pi k akt
- climate change
- coronary artery disease
- replacement therapy
- sensitive detection
- rectal cancer